Illumina and Veritas Genetics announced a consortium to integrate whole‑genome sequencing (WGS) into preventive healthcare, combining Illumina’s sequencing and DRAGEN analysis with Veritas’ clinical reporting and genetic counseling. The program will offer opt‑in preventive genomics with confirmatory testing pathways, specialist referrals and guideline‑aligned screening, the companies said. Illumina framed the effort as moving genomics upstream from diagnosis to prevention and creating a consented clinical‑genomics dataset to support precision‑medicine partnerships. The consortium will target actionable findings and streamlined participant experiences, and seeks to demonstrate clinical utility in routine care settings.